Accessibility Menu
 
Rosetta Genomics logo

Rosetta Genomics

(OTC) ROSGQ

Current Price$0.00
Market Cap$600
Since IPO (2007)-100%
5 Year-100%
1 Year+0%
1 Month-50%

Rosetta Genomics Financials at a Glance

Market Cap

$600

Revenue (TTM)

$5.49M

Net Income (TTM)

$14.27M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-22.18 (Low)

Price

$0.00

Volume

2,544

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

ROSGQ News

No articles available.

ROSGQ: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Rosetta Genomics

Industry

Biotechnology

Headquarters

Rehovot, 76706, IL

ROSGQ Financials

Key Financial Metrics (TTM)

Gross Margin

19%

Operating Margin

-2%

Net Income Margin

-2%

Return on Equity

0%

Return on Capital

-2%

Return on Assets

-1%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$600.00

Shares Outstanding

5.93M

Volume

2.54K

Short Interest

0.00%

Avg. Volume

165.623

Financials (TTM)

Gross Profit

$1.79M

Operating Income

$15.66M

EBITDA

$15.32M

Operating Cash Flow

$10.37M

Capital Expenditure

$223.00K

Free Cash Flow

$10.59M

Cash & ST Invst.

$6.16M

Total Debt

$3.79M

Rosetta Genomics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q2 2017YOY CHG

Revenue

$870.00K

-66.6%

Gross Profit

$301.00K

-68.1%

Gross Margin

34.60%

N/A

Market Cap

$600.00

N/A

Market Cap/Employee

$6.98

N/A

Employees

86

N/A

Net Income

$2.07M

+48.7%

EBITDA

$1.37M

+65.8%

Quarterly Fundamentals

Name
Q2 2017YOY CHG

Net Cash

$1.12M

-109.4%

Accounts Receivable

$987.00K

-74.1%

Inventory

$0.00

N/A

Long Term Debt

$2.43M

N/A

Short Term Debt

$110.00K

N/A

Return on Assets

-1.36%

N/A

Return on Invested Capital

-1.92%

N/A

Free Cash Flow

$12.26M

N/A

Operating Cash Flow

$11.96M

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ONCSQOncoSec Medical Incorporated
$0.00+0.00%
MOTSMotus GI Holdings, Inc.
$0.00+0.00%
SIGOSunset Island Group, Inc.
$0.00+0.00%
HRALHear AtLast Holdings, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.82+0.06%
QQQInvesco QQQ Trust
$582.06-0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.12-0.07%

Questions About ROSGQ

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.